Cleome droserifolia
Cleome droserifolia · Accepted scientific name
Scientific literature: Very Sparse (7 studies) · ★☆☆☆☆
Cleome droserifolia is a versatile medicinal plant that has garnered significant scientific interest due to its diverse pharmacological activities. Research indicates that extracts from its leaves, particularly aqueous and chloroform fractions, possess potent antiatherogenic, antibacterial, antimalarial, and antidiabetic properties. These therapeutic effects are largely driven by key phytochemicals such as flavonoids, cyanidin 3-glucoside, isorhamnetin, and isoquercitrin. Specifically, the plant plays a crucial role in managing conditions like diabetes mellitus by addressing oxidative stress and regulating apoptosis. Through these organic extracts, Cleome droserifolia serves as a powerful natural antioxidant in various medicinal applications.
- Synonyms
- Cleome Ovalifolia · Roridula Tetrandra · 6 more
- Common names
- Not available
- Family
- Cleomaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Synonyms
Cleome droserifolia is a taxonomically complex species that is associated with several important botanical synonyms. Within scientific literature, this plant is frequently identified as Cleome austroarabica, including the specific subspecies Cleome austroarabica subsp. muscatensis. Researchers may also encounter this organism under the names Cleome brachyadenia or Cleome ovalifolia depending on the classification system used. Additionally, the name Cleome pruinosa serves as another recognized synonym for this particular plant. Understanding these various nomenclatural relationships is essential for accurate identification and study in the field of botany.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Cleome droserifolia is a distinctive member of the kingdom Plantae. Within this vast biological realm, it is classified under the class Equisetopsida. This plant belongs to the specific genus Cleome, which showcases its unique botanical traits. Furthermore, it is situated within the family Cleomaceae, highlighting its evolutionary lineage. Finally, its taxonomic journey places it firmly within the order Brassicales.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Brassicales |
| Family | Cleomaceae |
| Genus | Cleome |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Cleome droserifolia is a plant species primarily concentrated throughout the diverse landscapes of Northeast Tropical Africa. Its geographic range extends across several key regions, including Djibouti and Eritrea, where it maintains established populations. The species is also found within the unique environments of Socotra and the nation of Somalia. Furthermore, its distribution reaches into the territories of both Sudan and South Sudan. This widespread presence across the Horn of Africa highlights the plant's ability to thrive in various regional habitats.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Cleome droserifolia is characterized by its distinct growth form as a subshrub.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Cleome droserifolia is a medicinal plant that demonstrates a diverse range of therapeutic activities across several biological targets. Research indicates that its extracts possess significant antidiabetic properties by suppressing blood glucose and inhibiting key enzymes like DPPIV. The plant also exhibits strong antimicrobial and antibacterial effects, specifically showing the ability to combat Staphylococcus aureus infections and reduce biofilm formation. Furthermore, its ability to improve lipid metabolism provides valuable antiatherogenic benefits by modulating cholesterol ratios. Finally, studies on wild Egyptian flora have identified its potential as an antimalarial agent against Plasmodium falciparum.
Compounds
Cleome droserifolia is a medicinal plant that contains a diverse array of bioactive chemical constituents. Research has identified the flavonoid 8-Methoxycirsilineol within its methanol extract, where it contributes to the suppression of nitric oxide production. Additionally, the plant contains several terpenoids, specifically identified as compounds C1, C2, C3, and C4. These specific compounds have been isolated from active fractions during studies regarding the plant's antidiabetic properties. Ultimately, the presence of these various molecules underscores the complex chemical profile responsible for the plant's therapeutic potential.
Conditions
Cleome droserifolia serves as a potent therapeutic agent for the treatment of diabetes mellitus by suppressing blood glucose concentrations and improving insulin sensitivity. The plant's bioactive constituents, such as flavonol glycosides, effectively combat oxidative stress through significant antioxidant capacities. Research indicates that extracts of the plant also help manage liver function by significantly decreasing levels of ALT and ALP. These metabolic improvements are further supported by the plant's ability to ameliorate various biochemical parameters associated with diabetic complications. Consequently, Cleome droserifolia demonstrates a comprehensive medicinal profile in treating diabetes and its related physiological stressors.
Preparations
Cleome droserifolia is prepared as organic extracts to demonstrate effective caspase-dependent anticancer activity in human cancer cell lines. The plant is also prepared as aqueous (AqEx) extracts, which have been shown to increase basal glucose uptake in skeletal muscle cells. Researchers utilize aqueous extracts to identify major flavonol glycosides that can inhibit enzymes like DPPIV. Additionally, Cleome droserifolia is prepared as ethanolic (AlEx) extracts to test for antidiabetic activities in cultured adipocytes and muscle cells. Finally, the plant is prepared as chloroform (ClFr) fractions to isolate bioactive terpenoids and study their effects on glucose uptake and triglyceride accumulation.
Parts used
Cleome droserifolia leaves serve as a vital component in the study of traditional medicinal plants with therapeutic potential. Research involving these specific leaf extracts has focused on their significant insulinotropic and anti-obesity properties. Through advanced UHPLC/QTOF-MS/MS analysis, the main constituents of the leaves were identified to understand their pharmacological impact. In vivo testing on diabetic rat models demonstrated that the herbal extracts effectively increased insulin secretion and promoted weight reduction. These findings suggest that Cleome droserifolia leaves offer a promising natural approach for managing metabolic disorders.